Loading chart…
PRE-MARKET
Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas.
Aurobindo Pharma Limited (AUROPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AUROPHARMA share price is ₹1,800.00 (+0.84% today), with a market capitalisation of ₹1.04T and a price-to-earnings (P/E) ratio of 26.1. MarketRipple tracks the AUROPHARMA investment thesis, the ripple-chain impact of market events on Aurobindo Pharma Limited, and the Healthcare sector outlook.
Open
₹1,784.30
High
₹1,805.00
Low
₹1,776.00
Prev. Close
₹1,785.00
52W High
₹1,805.00
52W Low
₹1,106.00
Day range
₹1,776.00–₹1,805.00
52-week range
₹1,106.00–₹1,805.00
Volume
1.3M
P/E
26.1
ROE
10.7%
D/E
0.21
Margin
10.8%
Aurobindo Pharma Limited (NSE: AUROPHARMA) is currently trading at ₹1,800.00 (+0.84%).
Aurobindo Pharma Limited's market capitalization is ₹1.04T.
Aurobindo Pharma Limited's price-to-earnings (P/E) ratio is 26.1.
Aurobindo Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Aurobindo Pharma Limited currently reads positive, based on 26 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.